Novel Approaches to Targeting Innate Immunity for Cancer Immunotherapy PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Novel Approaches to Targeting Innate Immunity for Cancer Immunotherapy PDF full book. Access full book title Novel Approaches to Targeting Innate Immunity for Cancer Immunotherapy by Patrick H. Lizotte. Download full books in PDF and EPUB format.
Author: Patrick H. Lizotte Publisher: ISBN: Category : Languages : en Pages : 236
Book Description
Many kinds of cancer, and almost universally metastatic cancer, are refractory to treatment by conventional methods: surgery radiation, and non-specific cytotoxic chemotherapy. The dawn of the age of personalized medicine presaged 15 years ago with the completion of the human genome project has thus far largely failed to deliver on the promise of targeted therapeutics. We have recently seen the development of immunotherapy as a compliment to these methods. Immunotherapies hold an advantage in that they are not specific to driver mutations or oncogenic pathways that may change, but recognize an array of tumors antigens and can adapt over time to the emergence of new tumor cell populations with new characteristic mutations and antigens. In order to achieve systemic long-lasting anti-tumor immunity, immunosuppression in the tumor microenvironment must be overcome. We have developed technologies to accomplish this through the targeting and activation of immunosuppressive innate leukocytes that without treatment would otherwise promote tumor survival, growth, and metastasis, and inhibit the establishment of tumor-specific immunity. We have utilized an attenuated strain of Listeria monocytogenes and the self-assembling eCPMV viral-like nanoparticle. These two immunotherapies target innate leukocytes in the tumor microenvironment and induce their production of pro-inflammatory cytokines and chemokines that recruit in new effector cell subsets. Listeria and eCPMV show clear efficacy in mouse models of melanoma, ovarian carcinoma, colon cancer, and breast carcinoma. Our results highlight the value in emerging therapeutic strategies that target immunosuppressive innate immune cells in the tumor microenvironment.
Author: Patrick H. Lizotte Publisher: ISBN: Category : Languages : en Pages : 236
Book Description
Many kinds of cancer, and almost universally metastatic cancer, are refractory to treatment by conventional methods: surgery radiation, and non-specific cytotoxic chemotherapy. The dawn of the age of personalized medicine presaged 15 years ago with the completion of the human genome project has thus far largely failed to deliver on the promise of targeted therapeutics. We have recently seen the development of immunotherapy as a compliment to these methods. Immunotherapies hold an advantage in that they are not specific to driver mutations or oncogenic pathways that may change, but recognize an array of tumors antigens and can adapt over time to the emergence of new tumor cell populations with new characteristic mutations and antigens. In order to achieve systemic long-lasting anti-tumor immunity, immunosuppression in the tumor microenvironment must be overcome. We have developed technologies to accomplish this through the targeting and activation of immunosuppressive innate leukocytes that without treatment would otherwise promote tumor survival, growth, and metastasis, and inhibit the establishment of tumor-specific immunity. We have utilized an attenuated strain of Listeria monocytogenes and the self-assembling eCPMV viral-like nanoparticle. These two immunotherapies target innate leukocytes in the tumor microenvironment and induce their production of pro-inflammatory cytokines and chemokines that recruit in new effector cell subsets. Listeria and eCPMV show clear efficacy in mouse models of melanoma, ovarian carcinoma, colon cancer, and breast carcinoma. Our results highlight the value in emerging therapeutic strategies that target immunosuppressive innate immune cells in the tumor microenvironment.
Author: Paul D. Rennert Publisher: Springer ISBN: 3319298275 Category : Medical Languages : en Pages : 285
Book Description
Cancer care is undergoing a radical transformation as novel technologies are directed toward new treatments and personalized medicine. The most dramatic advances in the treatment of cancer have come from therapeutics that augment the immune response to tumors. The immune checkpoint inhibitors are the best-known and most highly advanced examples of Immune Therapeutics targeting tumor cells and include approved antibody drugs directed at the cell surface proteins CTLA4 and PD-1. These are now considered foundational treatments for several solid tumor indications, and that list of indications is growing quickly. More broadly, antibodies have become workhorse molecules across the entire immunotherapy landscape. Antibodies to novel targets modulate the activity of diverse immune cell regulatory proteins. Engineered antibodies can induce tumor cell death or expose tumor cells to poisonous toxins (ADCC and ADC, respectively). Bi-specific antibodies can engage multiple tumor targets simultaneously, or can redirect lymphocytes to attack tumor cells. The antigen-binding domains within antibodies can be spliced onto cell stimulatory domains and transduced into T cells or NK cells, creating remarkable tumor-specific cellular therapeutics (CAR-T, CAR-NK). Beyond antibody-based therapies there are highly diverse and differentiated technology tool kits being applied to immunotherapy. Small molecule drugs are being developed to attack the tumor microenvironment, novel tumor vaccine approaches are showing great promise, patient lymphocytes are being isolated, expanded and reintroduced to patients, gene-editing techniques are becoming widely deployed, and a vast number of new tumor targets, and mutated tumor proteins (neoantigens), are being discovered. The past decade has seen unprecedented success in the treatment of diverse cancers. The authors of this volume have been asked to not only review progress to date, but importantly, to look ahead, and anticipate the evolution of cancer treatment across diverse Immune Therapeutic approaches. Our hypothesis is that the advances we are seeing across the immunotherapy landscape will further evolve and synergize, leading us finally to outright cures for many cancers.
Author: Mansoor M. Amiji Publisher: Academic Press ISBN: 012823637X Category : Business & Economics Languages : en Pages : 550
Book Description
Delivery Technologies for Immuno-Oncology: Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy examines the challenges of delivering immuno-oncology therapies. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited. Nanotechnology-based targeted delivery strategies could improve the delivery efficiency of IO agents as well as provide additional avenues for novel therapeutic and vaccination strategies. Additionally, a number of locally-administered immunogenic scaffolds and therapeutic strategies, such as the use of STING agonist, could benefit from rationally designed biomaterials and delivery approaches. Delivery Technologies for Immuno-Oncology: Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side. Comprehensive treaty covering all aspects of immuno-oncology (IO) Novel strategies for delivery of IO therapeutics and vaccines Forecasting on the future of nanotechnology and drug delivery for IO
Author: Robert C. Rees Publisher: OUP Oxford ISBN: 0191664553 Category : Medical Languages : en Pages : 496
Book Description
Patients are beginning to benefit from antibody based, cellular and vaccine approaches that are effective against genetically diverse and therapy-resistance cancers. BCG immunotherapy is now being used as a first line treatment for human bladder cancer and the introduction of prophylactic vaccination against Hepatitis B and HPV cancers is starting to show positive results. Following recent FDA approval for a vaccination against prostate cancer, and optimistic results in clinical trials for a vaccine targeting cancer antigens in lung cancer, cancer immunotherapy is now significantly impacting patient clinical management. Tumor Immunology and Immunotherapy provides an up-to-date and comprehensive account of cancer immunity and immunotherapy. It discusses our adaptive and innate immunity to cancer, the mechanisms underpinning our immune response, current approaches to cancer immunotherapy, and how tumour and host responses can circumvent effective anti-cancer immunity. The book examines recent results, publications and current areas of interest including 'immune editing' and the specific issues that are affecting the research and development of vaccines, providing insight into how these problems may be overcome, as viewed by world leaders in the field. Tumor Immunology and Immunotherapy will appeal to clinicians working in oncology and cancer immunotherapy, and research scientists including PhD and masters students, post-doctoral researchers and senior investigators.
Author: Hilal Arnouk Publisher: BoD – Books on Demand ISBN: 9533079983 Category : Medical Languages : en Pages : 232
Book Description
Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical researchers have joined forces to collaborate and review current developments and trends in cancer immunology for the purposes of this book, and the result is a promising review of contemporary clinical treatments. In each chapter the authors present the scientific basis behind such therapeutic approaches, including cancer vaccines with special focus on prostate cancer, melanoma and novel approaches utilizing both innate and adaptive immune responses.
Author: Sujata P. Sawarkar Publisher: Springer Nature ISBN: 9811590389 Category : Medical Languages : en Pages : 267
Book Description
This book illustrates the significance and relevance of immunotherapy in modern-day therapeutics. Focusing on the application of immunotherapy in oncology, neurodegenerative and autoimmune diseases, it discusses the drug delivery systems, and pre-clinical and clinical methodologies for immunotherapy-based drugs. It also comprehensively reviews various aspects of immunotherapy, such as regulatory affairs, quality control, safety, and pharmacovigilance. Further, the book discusses the in vitro validation of therapeutic strategies prior to patient application and management of immunotherapy-related side effects and presents case studies demonstrating the design and development (pre-clinical to clinical) of immunotherapy for various diseases. It also describes various design considerations and the scale-up synthesis of immunotherapeutics and screening methods. Lastly, it explores the important aspect of cost-effectiveness and rational immunotherapy strategies.
Author: Bénédicte Manoury Publisher: Frontiers Media SA ISBN: 2889458334 Category : Languages : en Pages : 166
Book Description
The most efficient way to mount a sustained immune response is to target antigens to antigen presenting cells that trigger both innate and adaptive immune responses. A comprehensive view of the current approaches to the design of new antigenic formulations will enhance our understanding and perspective of targeted immunotherapy. The aim of this Research Topic is to provide an overview of the currently adopted targeting strategies by a collection of articles on: 1.Novel approaches of antigen targeting for immunotherapeutic strategies against cancer and/or infectious diseases. 2. Diversity and biology of dendritic cell subsets in human and mouse. 3. Combined strategies for the delivery of antigens and adjuvant molecules that stimulate innate immune responses and their influence on the quality of immune responses. 4. Impact of the receptor mediate intracellular trafficking on antigen presentation.
Author: Nima Rezaei Publisher: Springer Nature ISBN: 3030502872 Category : Medical Languages : en Pages : 681
Book Description
This translational, clinically oriented book describes in detail novel approaches to cancer immunotherapy, current strategies to target tumor immunosuppression, and prognostic biomarkers for personalized cancer treatments. Since the first, very successful edition of the book was published in 2015, the original chapters have been significantly updated and entirely new chapters are included on, for example, cancer immunoprevention, aptamer-mediated cancer gene therapy, haploidentical bone marrow transplantation for pediatric malignancies, and nanoimmunotherapy. The book is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and cancer immunotherapy for organ-specific tumors. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers will be of special value to clinical immunologists, hematologists, and oncologists.
Author: Lisa H. Butterfield, PhD Publisher: Springer Publishing Company ISBN: 1617052736 Category : Medical Languages : en Pages : 921
Book Description
“Drs. Butterfield, Kaufman and Marincola on behalf of the SITC have created a comprehensive must-have resource covering the basic and translational science behind approved and investigational immune therapies, and disease-by-disease clinical application of the therapies, written by leaders in the field. The textbook will be highly valuable reading for those just entering the field and for experienced scientists and clinicians looking to expand their knowledge base.” —Mario Sznol, MD, Professor of Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut “Given the important and exciting advances in cancer immunotherapy, it is not surprising that there is no dearth of books on the subject. Despite the competition, however, this book is a unique masterpiece and a must-have comprehensive resource for anyone interested in this area and for every medical library.” Score: 100, 5 Stars, Doody’s Medical Reviews Cancer Immunotherapy Principles and Practice, from the Society for Immunotherapy of Cancer (SITC), is the authoritative reference on cancer immunobiology and the immunotherapy treatments that harness the immune system to combat malignant disease. Featuring five sections and over 50 chapters covering the Basic Principles of Tumor Immunology, Cancer Immunotherapy Targets and Classes, Immune Function in Cancer Patients, Disease-Specific Treatments and Outcomes, and Regulatory Aspects of Cancer Immunotherapy, this book covers all major topics that have shaped the development of immunotherapy and propelled it to its current place at the forefront of cancer treatment innovation. This volume is a comprehensive resource for oncologists and fellows, immunologists, cancer researchers, and related practitioners seeking understanding of the basic science and clinical applications of cancer immunotherapy. As well as presenting the evidence for immune-based cancer treatment, it positions immunotherapy in the context of other available cancer treatments and provides data on response rates, risks, and toxicities across a variety of diseases. Filled with detailed tables, and instructive illustrations, as well as key points for quick reference, Cancer Immunotherapy Principles and Practice simplifies a challenging and dynamic subject. KEY FEATURES Clearly summarizes the basic principles and research supporting cancer immunotherapy clinical translation Contains expert guidance and treatment strategies for all immunotherapy classes and agents, including cell-based therapies, monoclonal antibodies, cytokine therapies, checkpoint inhibitors, oncolytic viruses, adjuvant approaches, and treatment combinations Includes expert perspectives from leading authorities in the field Provides information on all FDA-approved immunotherapies, including clinical management and outcome data Discusses clinical aspects of immunotherapy for individual cancer types, including melanoma and other skin cancers, lung cancers, gynecologic cancers, gastrointestinal cancers, hematologic cancers, genitourinary cancers, head and neck cancers, sarcomas, brain and other CNS cancers, breast cancer, and pediatric malignancies. Explains regulatory aspects behind the development and approval of immunotherapy drugs
Author: Patrick H. Lizotte
Author: Patrick H. Lizotte
Author: Paul D. Rennert
Author: Virginie Lafont
Author: Mansoor M. Amiji
Author: Robert C. Rees
Author: Hilal Arnouk
Author: Sujata P. Sawarkar
Author: Bénédicte Manoury
Author: Nima Rezaei
Author: Lisa H. Butterfield, PhD